Politics
The recent announcement by the U.S. Drug Enforcement Administration (DEA) signaling its intent to move Cannabis from Schedule I to Schedule III of the Controlled Substance Act (CSA) has stirred…
In the forthcoming Farm Bill, a clash of priorities looms large as various stakeholders vie to have their interests represented. Among the contenders are hemp businesses, marijuana companies, state regulators,…
At a recent hearing before the House Education and the Workforce Committee, Representative Lori Chavez-DeRemer (R-OR) expressed her support for the federal rescheduling of marijuana. She specifically addressed U.S. Department…
Since the inception of medical marijuana in Arkansas in 2019, the industry has experienced remarkable growth. With over three dozen storefronts, more than 102,000 registered patients, and revenue surpassing $1.1…
Ohio is poised to launch its adult-use marijuana market sooner than expected, thanks to the approval of a regulatory framework by the legislature’s Joint Committee On Agency Rule Review (JCARR).…
Recent polling suggests that Florida’s marijuana legalization ballot initiative may be struggling to gain enough support for passage. In response, the campaign behind the measure, Smart & Safe Florida, has…
The Drug Enforcement Administration (DEA) has delayed an administrative hearing concerning its proposed ban on two psychedelic compounds, DOI and DOC, amidst a constitutional challenge to the scheduling process. Here’s…
Ahead of further consideration by the New Hampshire Senate this week of a House-passed bill to legalize marijuana, the body’s president says he’s hoping the proposal fails to make it…
